Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolor Technologies is a medical device company specializing in innovative solutions for pain management, particularly for chronic headaches and facial pain. The company's primary product is the SphenoCath, a patented, FDA-cleared delivery device designed to perform sphenopalatine ganglion (SPG) blocks. This device allows for the precise, needle-less delivery of medication to the SPG via a transnasal approach, offering a minimally invasive alternative to traditional methods. The procedure is typically performed in an office setting and provides rapid relief for indications such as migraines, cluster headaches, and trigeminal neuralgia. Dolor Technologies focuses on improving patient comfort and clinical efficiency through its specialized catheter technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dolor Technologies.